Reagent kit for the detection and semi-quantitative determination of tetanus antitoxin in the passive hemagglutination reaction "Diagnosticum tetanus-RPGA" TU 21.20.23-011-96299156-2021 Composed of: 1. Diagnosticum erythrocyte tetanus 5.0 ml - 2 vials. 2. Ram erythrocytes formalized 50% 5.0 ml - 2 vials. 3. Sheep erythrocytes control 5.0 ml -1 vial. 4. Phosphate buffer solution (FBI) 3.2 ml - 4 vials. 5. Phosphate-buffered solution (FBI) with twin 6.4 ml - 4 vials. 6. Anti-tetanus control serum 1.0 ml -1 vial. 7. Instructions for use. 8. Quality passport. - Roszdravnadzor Registration РЗН 2022/16341

Access comprehensive regulatory information for Reagent kit for the detection and semi-quantitative determination of tetanus antitoxin in the passive hemagglutination reaction "Diagnosticum tetanus-RPGA" TU 21.20.23-011-96299156-2021 Composed of: 1. Diagnosticum erythrocyte tetanus 5.0 ml - 2 vials. 2. Ram erythrocytes formalized 50% 5.0 ml - 2 vials. 3. Sheep erythrocytes control 5.0 ml -1 vial. 4. Phosphate buffer solution (FBI) 3.2 ml - 4 vials. 5. Phosphate-buffered solution (FBI) with twin 6.4 ml - 4 vials. 6. Anti-tetanus control serum 1.0 ml -1 vial. 7. Instructions for use. 8. Quality passport. in the Russia medical device market through Pure Global AI's free database. This Class 2b medical device is registered under Roszdravnadzor registration number РЗН 2022/16341 and manufactured by OOO "BioHold". The device was registered on June 03, 2024.

This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.